Individualization of drug treatment - Need for optimization;Individualisierte Arzneimitteltherapie - Es gibt etwas zu verbessern

Therapeutische Umschau

Volumn 57, Issue 9, 2000, Pages 545-546

  Haefeli, Walter E ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PHARMACOLOGY; DOSE RESPONSE; DRUG ADMINISTRATION; EVIDENCE BASED MEDICINE; GERMANY; HUMAN; PATIENT CARE PLANNING; PATIENT COMPLIANCE; PRESCRIPTION; PROFESSIONAL PRACTICE; STANDARD; SWITZERLAND;

DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; GERMANY; HUMANS; PATIENT CARE PLANNING; PATIENT COMPLIANCE; PHARMACOLOGY, CLINICAL; PRESCRIPTIONS, DRUG; PROFESSIONAL PRACTICE; SWITZERLAND;

EID: 0034264981     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.57.9.545     Document Type: Article

References (9)

1. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA 1997; 277: 312-7.
2. Falconnier AD, Grimm Baettig E, Surber Ch, Haefeli WE. Einfluss einer individualisierten Dosierung bei Niereninsuffizienz auf die Medikamentenkosten. Schweiz Med Wochenschr 1996; 126 (Suppl 74/I); 10S (abstract #P143).
3. Kreppelt C. Medikationssicherheit im Spital. Schweiz Rundsch Med Prax 1993; 82: 1316-9.
4. Kähny-Simonius J. Arzneimittel-Inkompatibilitäten. Probleme bei der gleichzeitigen Verabreichung mehrerer Medikamente in Infusionslösungen. 1993; 82: 1320-7.
5. Jankel CA, Speedie SM. Detecting drug interactions: a review of the literature. DICP 1990; 24: 982-9.
6. Kastrissios H, Blaschke TF. Medication compliance as a feature in drug development. Annu Rev Pharmacol Toxicol 1997; 37: 451-75.
7. Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation. 1997; 95: 1085-90.
8. Arnet I, Haefeli WE. Obvious non-compliers show a higher self-esteem on a 14-item personality scale. Naunyn Schmiedeberg's Arch Pharmacol 1999; 359: R126.
9. Schlienger RG, Lüscher TF, Schoenenberger RA, Haefeli WE. Academic detailing improves identification and reporting of adverse drug events. Pharm World Sci 1999; 21: 110-5.